Kenneth I. Kaitin - 31 Mar 2026 Form 4 Insider Report for CURIS INC (CRIS)

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
01 Apr 2026, 07:51:27 UTC
Prior SEC filing
22 May 2025
Next SEC filing
09 Jul 2026
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Diantha Duvall, Attorney-in-fact

Key filing fact

Kenneth I. Kaitin filed Form 4 for CURIS INC (CRIS) on 01 Apr 2026.

Key facts

  • This page summarizes Kenneth I. Kaitin's Form 4 filing for CURIS INC (CRIS).
  • 1 reported transaction and 0 derivative rows are listed below.
  • Accepted by SEC: 01 Apr 2026, 07:51.

Change

  • Previous filing in this sequence was filed on 22 May 2025.
  • Current net transaction value: +$5,487.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001271823 Primary reporting owner

KAITIN KENNETH I

Relationship
Director
Address
128 SPRING STREET, BUILDING C - SUITE 500, LEXINGTON
Signature
/s/ Diantha Duvall, Attorney-in-fact
Signature date
01 Apr 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

CRIS transaction

Common Stock

Purchase

Transaction value
$5,487
Shares
+10,000
Change %
+711%
Price
$0.5487
Shares after
11,407
Date
31 Mar 2026
Ownership
Direct
* marks a reported price that did not pass the local price check.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .